The most common and well-characterized EGFR mutations are in-frame deletions in exon 19 (residues 747–750) and the L858R substitution in exon 21, which together account for approximately 80–90% of all the EGFR mutations in NSCLC. Here, EGFR is linked to non-small cell lung carcinoma.